Carregant...
One size doesn’t fit all in Ph-like ALL
In this issue of Blood, Tasian et al provide compelling evidence that tailored therapies are an effective strategy in treating genetically defined Philadelphia chromosome–like (Ph-like) acute lymphoblastic leukemia (ALL).(1)
Guardat en:
| Publicat a: | Blood |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5234224/ https://ncbi.nlm.nih.gov/pubmed/28082291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-11-749168 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|